173 related articles for article (PubMed ID: 18677635)
1. Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept.
Schnell O; Schöller K; Ruge M; Siefert A; Tonn JC; Kreth FW
J Neurol; 2008 Oct; 255(10):1495-502. PubMed ID: 18677635
[TBL] [Abstract][Full Text] [Related]
2. Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
Kunz M; Nachbichler SB; Ertl L; Fesl G; Egensperger R; Niyazi M; Schmid I; Tonn JC; Peraud A; Kreth FW
Cancer Med; 2016 Mar; 5(3):442-53. PubMed ID: 26714663
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
4. Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study.
Peraud A; Goetz C; Siefert A; Tonn JC; Kreth FW
Childs Nerv Syst; 2007 Jan; 23(1):39-46. PubMed ID: 16972111
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.
Suchorska B; Ruge M; Treuer H; Sturm V; Voges J
Neuro Oncol; 2011 Oct; 13(10):1133-42. PubMed ID: 21868412
[TBL] [Abstract][Full Text] [Related]
6. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
9. Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
Hadi I; Reitz D; Bodensohn R; Roengvoraphoj O; Lietke S; Niyazi M; Tonn JC; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2021 Feb; 16(1):40. PubMed ID: 33622365
[TBL] [Abstract][Full Text] [Related]
10. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
11. Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases.
Ruge MI; Kocher M; Maarouf M; Hamisch C; Treuer H; Voges J; Sturm V
Strahlenther Onkol; 2011 Jan; 187(1):7-14. PubMed ID: 21234527
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome.
Ruge MI; Kickingereder P; Simon T; Treuer H; Sturm V
J Neurooncol; 2012 Sep; 109(2):273-83. PubMed ID: 22580799
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases.
Ruge MI; Kickingereder P; Grau S; Hoevels M; Treuer H; Sturm V
J Neurooncol; 2011 Oct; 105(1):109-18. PubMed ID: 21479963
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.
Suchorska B; Hamisch C; Treuer H; Mahnkopf K; Lehrke RE; Kocher M; Ruge MI; Voges J
J Neurooncol; 2016 Oct; 130(1):123-131. PubMed ID: 27422129
[TBL] [Abstract][Full Text] [Related]
15. Iodine-125 brachytherapy as upfront and salvage treatment for brain metastases : A comparative analysis.
Romagna A; Schwartz C; Egensperger R; Watson J; Tonn JC; Belka C; Kreth FW; Nachbichler SB
Strahlenther Onkol; 2016 Nov; 192(11):780-788. PubMed ID: 27349709
[TBL] [Abstract][Full Text] [Related]
16. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.
El Majdoub F; Neudorfer C; Blau T; Hellmich M; Bührle C; Deckert M; Sturm V; Maarouf M
Strahlenther Onkol; 2015 Dec; 191(12):936-44. PubMed ID: 26307628
[TBL] [Abstract][Full Text] [Related]
19. Interstitial radiosurgery of low-grade gliomas.
Kreth FW; Faist M; Warnke PC; Rossner R; Volk B; Ostertag CB
J Neurosurg; 1995 Mar; 82(3):418-29. PubMed ID: 7861220
[TBL] [Abstract][Full Text] [Related]
20. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
